The Hopkins group is conducting a clinical trial of the xenograft model in40 patients undergoing surgery at Johns Hopkins for non-metastatic pancreas cancer.
The chemotherapy by transarterial infusion (TAT) primarily combined with the 3D conformal radiation therapy in treating pancreas cancer
